Stockreport

Accord BioPharma, Inc. Announces Completion of UDENYCA® (pegfilgrastim-cbqv) Franchise Acquisition from Coherus BioSciences, Inc., Expanding U.S. Biosimilar Portfolio [Yahoo! Finance]

Coherus BioSciences, Inc.  (CHRS) 
Last coherus biosciences, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.coherus.com
PDF RALEIGH, N.C. April 14, 2025 /PRNewswire/ -- Accord BioPharma , Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology [Read more]